Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II, Multicentre, Randomised, Controlled, and Open-label Trial Comparing the Efficacy and Safety of Three Dose Regimens of BioChaperone PDGF-BB to Becaplermin Gel for the Treatment of Diabetic Foot Ulcer

NCT01098357 is registered in ClinicalTrials.gov with Virchow Group as lead sponsor.

NCT NCT01098357
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01098357 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II, Multicentre, Randomised, Controlled, and Open-label Trial Comparing the Efficacy and Safety of Three Dose Regimens of BioChaperone PDGF-BB to Becaplermin Gel for the Treatment of Diabetic Foot Ulcer
Lead sponsor
Virchow Group
Phase
Phase 1/2
Overall status
Completed
Start date
June 30, 2010
Completion date
September 30, 2011
Enrollment
192 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic foot ulcers